HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$5.54
Day range
$5.38 - $5.70
Year range
$3.79 - $14.60
Market cap
301.37M USD
Avg Volume
852.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.34M | 16.57% |
Net income | -4.80M | 78.43% |
Net profit margin | — | — |
Earnings per share | -0.20 | — |
EBITDA | -10.94M | -31.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.69M | 369.32% |
Total assets | 105.97M | 300.11% |
Total liabilities | 15.76M | -56.78% |
Total equity | 90.21M | — |
Shares outstanding | 54.90M | — |
Price to book | 3.38 | — |
Return on assets | -27.68% | — |
Return on capital | -30.35% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.80M | 78.43% |
Cash from operations | -8.89M | -43.45% |
Cash from investing | -31.00K | -416.67% |
Cash from financing | 17.44M | 796.86% |
Net change in cash | 8.52M | 300.09% |
Free cash flow | -10.68M | -254.96% |
About
Founded
2003
Headquarters
Website
Employees
38
